Rosa Aguero, NP
Nurse Practitioner · Riverside
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 6 years
- Graduated 2020
Offices
1 location · Ehab Yacoub MD Inc · 179 clinicians in this group
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Rosa Aguero’s office at (877) 515-8113 to ask if they take your plan before you enroll.
Original Medicare doctor bills
$21,851
Medicare paid this office $21,851 for 21 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 20 | $13,920 | $89 |
| Psychotherapy with evaluation and management visit, 30 minutes | 19 | $4,287 | $49 |
| Psychotherapy with evaluation and management visit, 45 minutes | 15 | $3,222 | $62 |
Who their Medicare patients are
21 Original Medicare patients in 2024. Average age 56 · Health risk score 1.01. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: Depression 71% · High blood pressure 57%.
The office billed $74,850, Medicare allowed $28,962 and paid $21,851; for 302 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 21 | 302 | 56 | 1.01 | $74,850 | $21,851 |
| 2023 | 55 | 343 | 61 | 2.89 | $100,800 | $25,457 |
| 2022 | 151 | 880 | 64 | 2.94 | $108,650 | $54,910 |
| 2021 | 35 | 176 | 63 | 3.21 | $23,650 | $12,491 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Return visit (30+ min) | 16 | $8,639 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $5,253 | $85 |
| Psychotherapy with evaluation and management visit, 30 minutes | 17 | $2,926 | $49 |
| Psychotherapy with evaluation and management visit, 45 minutes | 12 | $2,321 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $1,606 | $124 |
| Psychotherapy with evaluation and management visit, 30 minutes | 19 | $1,526 | $44 |
| Psychotherapy with evaluation and management visit, 45 minutes | 20 | $1,437 | $55 |
2022: 5 services
| Psychotherapy with evaluation and management visit, 30 minutes | 120 | $16,649 | $45 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 96 | $13,910 | $142 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 84 | $11,013 | $73 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 48 | $7,965 | $51 |
| Psychotherapy with evaluation and management visit, 45 minutes | 68 | $3,873 | $57 |
2021: 4 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $4,077 | $146 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $3,154 | $75 |
| Psychotherapy with evaluation and management visit, 30 minutes | 27 | $2,880 | $46 |
| Psychotherapy with evaluation and management visit, 45 minutes | 24 | $1,387 | $58 |
Medicaid work
$395,449 in 2024
Medicaid paid $395,449 for 2,152 billed services this clinician did in 2024, up to 193 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 1,590 | $312,797 |
| Psychotherapy, 45 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 271 | $50,164 |
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 291 | $32,488 |
| 2024 | 2,152 | 3 | 193 | $395,449 |
| 2023 | 3,395 | 8 | 217 | $647,619 |
| 2022 | 234 | 3 | 97 | $44,063 |
| 2021 | 282 | 1 | 83 | $51,431 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 2,535 | $542,450 |
| Psychiatric diagnostic evaluation with medical services | 146 | $34,679 |
| Psychotherapy, 45 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 209 | $29,990 |
| Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure) | 311 | $28,189 |
| New patient visit (60+ min) | 17 | $5,355 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 134 | $3,380 |
| IP/OBS CONSLTJ NEW/EST PT HIGH MDM 80 MINUTES | 30 | $2,291 |
| Short return visit | 13 | $1,285 |
2022
| Clinic visit/encounter, all-inclusive | 173 | $31,592 |
| Return visit (30+ min) | 37 | $7,001 |
| Psychiatric diagnostic evaluation with medical services | 24 | $5,469 |
2021
| Clinic visit/encounter, all-inclusive | 282 | $51,431 |
Drugs they prescribed that Part D paid
$85,040
Pharmacies billed $85,040 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,533) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
1,498 generic and 35 brand-name prescriptions · $85,040 in drug cost · 124 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Quetiapine | 132 | $2,304 | $17 |
| Aripiprazole | 51 | $2,194 | $43 |
| Hydroxyzine | 78 | $1,828 | $23 |
| Fluphenazine Decanoate | 11 | $1,225 | $111 |
| Ziprasidone | 24 | $1,147 | $48 |
See all 31 drugs
| Quetiapine | 132 | $2,304 | $17 |
| Aripiprazole | 51 | $2,194 | $43 |
| Hydroxyzine | 78 | $1,828 | $23 |
| Fluphenazine Decanoate | 11 | $1,225 | $111 |
| Ziprasidone | 24 | $1,147 | $48 |
| Clonazepam | 72 | $1,064 | $15 |
| Bupropion Xl | 47 | $983 | $21 |
| Trazodone | 120 | $767 | $6 |
| Risperidone | 44 | $734 | $17 |
| Buspirone | 49 | $728 | $15 |
| Ramelteon | 16 | $672 | $42 |
| Risperidone Odt | 11 | $660 | $60 |
| Mirtazapine | 22 | $596 | $27 |
| Bupropion Hcl Sr | 45 | $566 | $13 |
| Duloxetine | 68 | $490 | $7 |
| Venlafaxine Hcl Er | 32 | $484 | $15 |
| Benztropine Mesylate | 34 | $384 | $11 |
| Bupropion | 12 | $384 | $32 |
| Escitalopram | 59 | $379 | $6 |
| Paroxetine | 56 | $376 | $7 |
| Sertraline | 88 | $363 | $4 |
| Lorazepam | 67 | $263 | $4 |
| Methylphenidate Er | 11 | $250 | $23 |
| Olanzapine | 29 | $249 | $9 |
| Fluoxetine | 48 | $246 | $5 |
| Prazosin | 35 | $241 | $7 |
| Divalproex | 20 | $185 | $9 |
| Diazepam | 25 | $183 | $7 |
| Propranolol | 13 | $175 | $13 |
| Hydroxyzine Pamoate | 12 | $111 | $9 |
| Alprazolam | 31 | $89 | $3 |
Year by year
| 2024 | 1,533 | 69 | 0% (0) | 2% | $85,040 |
| 2023 | 789 | 86 | 0% (0) | 3% | $54,963 |
| 2022 | 499 | 61 | 0% (0) | 6% | $78,846 |
| 2021 | 641 | 57 | 0% (0) | 8% | $88,641 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 24 drugs
| Aripiprazole | 46 | $3,185 | $69 |
| Quetiapine | 77 | $2,715 | $35 |
| Sertraline | 80 | $2,447 | $31 |
| Hydroxyzine | 34 | $1,402 | $41 |
| Risperidone | 29 | $1,263 | $44 |
| Fluoxetine | 38 | $1,182 | $31 |
| Trazodone | 78 | $996 | $13 |
| Buspirone | 32 | $830 | $26 |
| Venlafaxine Hcl Er | 15 | $711 | $47 |
| Duloxetine | 16 | $656 | $41 |
| Paroxetine | 32 | $557 | $17 |
| Bupropion Xl | 26 | $542 | $21 |
| Clonazepam | 32 | $528 | $17 |
| Venlafaxine | 11 | $510 | $46 |
| Mirtazapine | 19 | $476 | $25 |
| Escitalopram | 25 | $466 | $19 |
| Lorazepam | 37 | $464 | $13 |
| Prazosin | 12 | $411 | $34 |
| Bupropion Hcl Sr | 16 | $176 | $11 |
| Citalopram Hbr | 11 | $167 | $15 |
| Lithium Carbonate | 12 | $147 | $12 |
| Diazepam | 11 | $102 | $9 |
| Benztropine Mesylate | 11 | $96 | $9 |
| Alprazolam | 12 | $64 | $5 |
2022: 18 drugs
| Latuda | 14 | $23,989 | $1,713 |
| Fluphenazine | 12 | $8,198 | $683 |
| Aripiprazole | 43 | $7,706 | $179 |
| Quetiapine | 47 | $1,743 | $37 |
| Risperidone | 22 | $731 | $33 |
| Fluoxetine | 34 | $455 | $13 |
| Buspirone | 16 | $405 | $25 |
| Benztropine Mesylate | 18 | $389 | $22 |
| Propranolol | 18 | $349 | $19 |
| Trazodone | 32 | $301 | $9 |
| Prazosin | 11 | $202 | $18 |
| Sertraline | 20 | $196 | $10 |
| Lamotrigine | 28 | $185 | $7 |
| Mirtazapine | 11 | $143 | $13 |
| Gabapentin | 13 | $101 | $8 |
| Escitalopram | 15 | $100 | $7 |
| Zolpidem | 11 | $61 | $6 |
| Alprazolam | 11 | $32 | $3 |
2021: 23 drugs
| Latuda | 17 | $27,967 | $1,645 |
| Rexulti | 11 | $13,919 | $1,265 |
| Aripiprazole | 40 | $1,512 | $38 |
| Quetiapine | 43 | $1,177 | $27 |
| Quetiapine Fumarate Er | 21 | $970 | $46 |
| Fluvoxamine Maleate | 12 | $889 | $74 |
| Trazodone | 65 | $645 | $10 |
| Buspirone | 27 | $494 | $18 |
| Risperidone | 33 | $428 | $13 |
| Prazosin | 15 | $399 | $27 |
| Fluoxetine | 26 | $227 | $9 |
| Benztropine Mesylate | 14 | $195 | $14 |
| Olanzapine | 18 | $194 | $11 |
| Lamotrigine | 29 | $191 | $7 |
| Clonazepam | 14 | $160 | $11 |
| Escitalopram | 23 | $141 | $6 |
| Zolpidem | 26 | $131 | $5 |
| Alprazolam | 29 | $104 | $4 |
| Hydroxyzine | 16 | $101 | $6 |
| Gabapentin | 13 | $75 | $6 |
| Sertraline | 13 | $67 | $5 |
| Lorazepam | 11 | $46 | $4 |
| Hydroxyzine Pamoate | 11 | $41 | $4 |
Money from drug and device companies
$2,057 in 2025
| 2025 | 7 | 20 | None | $2,057 |
| 2024 | 1 | 2 | None | $285 |
| 2023 | 2 | 7 | None | $791 |
| 2022 | 4 | 7 | None | $1,013 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Pharmaceuticals | Invega Sustenna | $806 | 8 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $400 | 3 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $287 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Cobenfy | $254 | 2 payments
|
| Alkermes | Lybalvi | $130 | 1 payment
|
| Supernus Pharmaceuticals | Qelbree | $124 | 1 payment
|
See all 20 published payments
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-15 | Caplyta | $123 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-09 | Caplyta | $129 |
| Teva Pharmaceuticals USA | Education · 2025-12-05 | None | $76 |
| Teva Pharmaceuticals USA | Meals · 2025-12-04 | Austedo Xr | $86 |
| Janssen Pharmaceuticals | Meals · 2025-12-03 | Invega Sustenna | $92 |
| Axsome Therapeutics | Meals · 2025-11-18 | Auvelity | $25 |
| Alkermes | Meals · 2025-11-06 | Lybalvi | $130 |
| Teva Pharmaceuticals USA | Meals · 2025-10-16 | Austedo Xr | $125 |
| Axsome Therapeutics | Meals · 2025-10-14 | Auvelity | $31 |
| Supernus Pharmaceuticals | Meals · 2025-09-24 | Qelbree | $124 |
| Janssen Pharmaceuticals | Meals · 2025-09-09 | Invega Sustenna | $127 |
| Janssen Pharmaceuticals | Meals · 2025-07-17 | Invega Sustenna | $27 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-07-16 | Cobenfy | $133 |
| Janssen Pharmaceuticals | Meals · 2025-05-23 | Invega Sustenna | $127 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-16 | Cobenfy | $120 |
| Janssen Pharmaceuticals | Meals · 2025-04-04 | Invega Sustenna | $114 |
| Janssen Pharmaceuticals | Meals · 2025-04-01 | Invega Sustenna | $33 |
| Janssen Pharmaceuticals | Meals · 2025-03-11 | Invega Sustenna | $150 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-02-12 | Caplyta | $148 |
| Janssen Pharmaceuticals | Meals · 2025-02-06 | Invega Sustenna | $136 |
See earlier years (2024, 2023, 2022)
2024: $285
| Janssen Pharmaceuticals | Invega Sustenna | $285 | 2 payments
|
2023: $791
| Janssen Pharmaceuticals | Invega Sustenna | $551 | 5 payments
|
| Iti | Caplyta | $241 | 2 payments
|
2022: $1,013
| Janssen Pharmaceuticals | Invega Sustenna | $394 | 3 payments
|
| Iti | Caplyta | $330 | 2 payments
|
| Neurocrine Biosciences | Ingrezza | $170 | 1 payment
|
| Otsuka America Pharmaceutical | Jynarque | $120 | 1 payment
|
Professional record
- NPI
- 1215534888
- Licence
- CA 787372
- Group
- Ehab Yacoub MD Inc
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X)
- Mailing address
- 13751 Terrace Pl, Whittier, CA, 90601
- NPI first listed
- 2020-10-06
- NPI last updated
- 2025-01-17
- NPI record certified
- 2025-01-17
This is when the NPI record was last certified, not a medical board exam.